Since the initial work, a decade ago the combination of C-reactive protein and albumin, the Glasgow Prognostic Score (GPS/mGPS), has been shown to have independent prognostic value in more than 60 studies (>30,000 patients with cancer). This evidence concerns the gene ALB and cancer.